Drug Profile
GSK 163090
Alternative Names: 163090; GSK-163090Latest Information Update: 18 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Antidepressants; Anxiolytics
- Mechanism of Action 5-HT1 serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 26 Jun 2012 Discontinued before 2012 for Anxiety disorders in Germany (PO)
- 26 Jun 2012 Discontinued before 2012 for Anxiety disorders in USA (PO)
- 26 Jun 2012 Discontinued before 2012 for Major depressive disorder in Canada (PO)